Literature DB >> 11408233

In vitro antibiotic susceptibilities of Burkholderia mallei (causative agent of glanders) determined by broth microdilution and E-test.

H S Heine1, M J England, D M Waag, W R Byrne.   

Abstract

In vitro susceptibilities to 28 antibiotics were determined for 11 strains of Burkholderia mallei by the broth microdilution method. The B. mallei strains demonstrated susceptibility to aminoglycosides, macrolides, quinolones, doxycycline, piperacillin, ceftazidime, and imipenem. For comparison and evaluation, 17 antibiotic susceptibilities were also determined by the E-test. E-test values were always lower than the broth dilution values. Establishing and comparing antibiotic susceptibilities of specific B. mallei strains will provide reference information for assessing new antibiotic agents.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11408233      PMCID： PMC90610          DOI： 10.1128/AAC.45.7.2119-2121.2001

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  14 in total

1.  Experimental chemotherapy in glanders and melioidosis.

Authors:  W R MILLER; L PANNELL; M S INGALLS
Journal:  Am J Hyg       Date:  1948-03

2.  In vitro susceptibilities of Burkholderia mallei in comparison to those of other pathogenic Burkholderia spp.

Authors:  D J Kenny; P Russell; D Rogers; S M Eley; R W Titball
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

3.  In vitro susceptibility of Pseudomonas mallei to antimicrobial agents.

Authors:  S A Al-Izzi; L S Al-Bassam
Journal:  Comp Immunol Microbiol Infect Dis       Date:  1989       Impact factor: 2.268

Review 4.  The pseudomallei group: a review.

Authors:  C Howe; A Sampath; M Spotnitz
Journal:  J Infect Dis       Date:  1971-12       Impact factor: 5.226

5.  [Sensitivity of Pseudomonas mallei to sulfanilamide combinations in vitro].

Authors:  N A Lozovaia
Journal:  Antibiot Khimioter       Date:  1989-01

6.  Laboratory-acquired human glanders--Maryland, May 2000.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2000-06-23       Impact factor: 17.586

7.  Melioidosis: a major cause of community-acquired septicemia in northeastern Thailand.

Authors:  W Chaowagul; N J White; D A Dance; Y Wattanagoon; P Naigowit; T M Davis; S Looareesuwan; N Pitakwatchara
Journal:  J Infect Dis       Date:  1989-05       Impact factor: 5.226

8.  [Sensitivity of Pseudomonas mallei to fluoroquinolones and their efficacy in experimental glanders].

Authors:  V P Batmanov
Journal:  Antibiot Khimioter       Date:  1991-09

9.  Comparison of five methods, including the PDM Epsilometer test (E test), for antimicrobial susceptibility testing of Pseudomonas aeruginosa.

Authors:  L F Joyce; J Downes; K Stockman; J H Andrew
Journal:  J Clin Microbiol       Date:  1992-10       Impact factor: 5.948

10.  [Sensitivity of Pseudomonas mallei to tetracyclines and their effectiveness in experimental glanders].

Authors:  V P Batmanov
Journal:  Antibiot Khimioter       Date:  1994-05
View more
  20 in total

1.  Horizontal gene transfer of "prototype" Nramp in bacteria.

Authors:  Etienne Richer; Pascal Courville; Isabelle Bergevin; Mathieu F M Cellier
Journal:  J Mol Evol       Date:  2003-10       Impact factor: 2.395

2.  Use of a recombinant burkholderia intracellular motility a protein for immunodiagnosis of glanders.

Authors:  Subodh Kumar; Praveen Malik; Shailendra Kumar Verma; Vijai Pal; Vandana Gautam; Chiranjay Mukhopadhyay; Ganga Prasad Rai
Journal:  Clin Vaccine Immunol       Date:  2011-07-13

3.  Efficacy of postexposure therapy against glanders in mice.

Authors:  David M Waag
Journal:  Antimicrob Agents Chemother       Date:  2015-02-02       Impact factor: 5.191

4.  Evaluation of PCR, DNA hybridization and immunomagnetic separation - PCR for detection of Burkholderia mallei in artificially inoculated environmental samples.

Authors:  S Merwyn; S Kumar; G S Agarwal; G P Rai
Journal:  Indian J Microbiol       Date:  2010-03-05       Impact factor: 2.461

5.  The type IV pilin of Burkholderia mallei is highly immunogenic but fails to protect against lethal aerosol challenge in a murine model.

Authors:  Paula J Fernandes; Qin Guo; David M Waag; Michael S Donnenberg
Journal:  Infect Immun       Date:  2007-04-02       Impact factor: 3.441

6.  Present and future therapeutic strategies for melioidosis and glanders.

Authors:  D Mark Estes; Steven W Dow; Herbert P Schweizer; Alfredo G Torres
Journal:  Expert Rev Anti Infect Ther       Date:  2010-03       Impact factor: 5.091

7.  Peptidyl-Prolyl Isomerase ppiB Is Essential for Proteome Homeostasis and Virulence in Burkholderia pseudomallei.

Authors:  Nicole M Bzdyl; Nichollas E Scott; Isobel H Norville; Andrew E Scott; Timothy Atkins; Stanley Pang; Derek S Sarovich; Geoffrey Coombs; Timothy J J Inglis; Charlene M Kahler; Mitali Sarkar-Tyson
Journal:  Infect Immun       Date:  2019-09-19       Impact factor: 3.441

8.  In Vitro and In Vivo Characterization of Tebipenem (TBP), an Orally Active Carbapenem, against Biothreat Pathogens.

Authors:  Nicholas P Clayton; Akash Jain; Stephanie A Halasohoris; Lisa M Pysz; Sanae Lembirik; Steven D Zumbrun; Christopher D Kane; Michael J Hackett; Denise Pfefferle; M Autumn Smiley; Michael S Anderson; Henry Heine; Gabriel T Meister; Michael J Pucci
Journal:  Antimicrob Agents Chemother       Date:  2021-02-16       Impact factor: 5.191

9.  Biodefense-driven murine model of pneumonic melioidosis.

Authors:  J A Jeddeloh; D L Fritz; D M Waag; J M Hartings; G P Andrews
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

10.  Comparison of the in vitro and in vivo susceptibilities of Burkholderia mallei to Ceftazidime and Levofloxacin.

Authors:  Barbara M Judy; Gregory C Whitlock; Alfredo G Torres; D Mark Estes
Journal:  BMC Microbiol       Date:  2009-05-09       Impact factor: 3.605
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.